| Karl Andersen, DO | |
|
41 Mall Rd, Burlington, MA 01805-0001 | |
| (781) 744-8000 | |
| Not Available |
| Full Name | Karl Andersen |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 41 Mall Rd, Burlington, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033564927 | NPI | - | NPPES |
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
Researchers are discovering new ways to help ‘de-program' specialised cells so that they can be re-programmed to form a range of different types of tissue, an international meeting of stem cell biologists was told.
Antigenics Inc. announced that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (the "Staff") on December 30, 2009 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
A group led by Dr. Massimo Loda at the Dana Farber Cancer Institute, Boston, MA has generated a preclinical model of human prostate cancer that mimics the genetic and growth behavior of primary tumors. Their report can be found in the April 2010 issue of the American Journal of Pathology.
The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions.
Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick and early detection of cancers.
› Verified 2 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
Researchers are discovering new ways to help ‘de-program' specialised cells so that they can be re-programmed to form a range of different types of tissue, an international meeting of stem cell biologists was told.
Antigenics Inc. announced that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (the "Staff") on December 30, 2009 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
A group led by Dr. Massimo Loda at the Dana Farber Cancer Institute, Boston, MA has generated a preclinical model of human prostate cancer that mimics the genetic and growth behavior of primary tumors. Their report can be found in the April 2010 issue of the American Journal of Pathology.
The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions.
Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick and early detection of cancers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karl Andersen, DO 800 Washington St, Boston, MA 02111-1552 Ph: (617) 636-5000 | Karl Andersen, DO 41 Mall Rd, Burlington, MA 01805-0001 Ph: (781) 744-8000 |
News Archive
Researchers are discovering new ways to help ‘de-program' specialised cells so that they can be re-programmed to form a range of different types of tissue, an international meeting of stem cell biologists was told.
Antigenics Inc. announced that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (the "Staff") on December 30, 2009 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
A group led by Dr. Massimo Loda at the Dana Farber Cancer Institute, Boston, MA has generated a preclinical model of human prostate cancer that mimics the genetic and growth behavior of primary tumors. Their report can be found in the April 2010 issue of the American Journal of Pathology.
The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions.
Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick and early detection of cancers.
› Verified 2 days ago
Joseph Dubin, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd., Lahey Clinic, Burlington, MA 01805 Phone: 781-744-7000 Fax: 781-744-5378 | |
Gerard Daly, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-5700 Fax: 781-744-5358 | |
Sahoor Khan, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Kristen M Robson, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8699 Fax: 781-744-5276 | |
Eric Scott Kerns, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Road, Lahey Hospital & Medical Center, Burlington, MA 01805 Phone: 781-744-8430 Fax: 781-744-5397 | |
Neethi Rebekah Dasu, DO Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Frederick W Heiss, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-5100 |